Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LC09 for Capecitabine-Induced Hand-Foot Syndrome
NCT02794493Phase 3Completed
- Sponsor
- China-Japan Friendship Hospital
- Start
- Apr 2015
- Primary completion
- Dec 2017
- Modality
- HM (Herbal Medicine)
01
Overview
Phase 3, randomised, double-blind trial in hand-foot syndrome (HFS) comparing LC09 Soak with Placebo Soak (2 arms). Primary endpoints: Grade of hand foot syndrome up to 6 weeks and Assessment of patient reported pain up to 6 weeks. Started Apr 2015; status: completed.
02
Drugs
Traditional Chinese Medicine Formula LC09
03
Conditions
hand-foot syndrome (HFS)
Beyond the preview
Go deeper on NCT02794493.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02794493.